newsfilter
← Latest News
GlobeNewswire·

NewAmsterdam Pharma to Present at the Stifel 2025 Virtual Cardiometabolic Forum

NAARDEN, The Netherlands and MIAMI, Sept. 24, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients